Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany - A nationwide population-based study in children and adults

Journal of Neurology

Volumn 259, Issue 11, 2012, Pages 2376-2384

  Hamer, Hajo M ^a   Dodel, Richard ^b   Strzelczyk, Adam ^b   Balzer Geldsetzer, Monika ^b   Reese, Jens Peter ^b   Schöffski, Oliver ^a   Graf, Wolfgang ^a   Schwab, Stefan ^a   Knake, Susanne ^b   Oertel, Wolfgang H ^b   Rosenow, Felix ^b   Kostev, Karel ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c IQVIA   (United States)

Author keywords

Antiepileptic drugs; Children; Costs; Elderly; Epilepsy; Prevalence

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; BROMIDE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ESLICARBAZEPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LORAZEPAM; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; RUFINAMIDE; STIRIPENTOL; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADULT; ARTICLE; CHILD; DRUG COST; DRUG UTILIZATION; EPILEPSY; FEMALE; GENERAL PRACTITIONER; GERMANY; HEALTH INSURANCE; HUMAN; MALE; MONOTHERAPY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DATABASES, FACTUAL; EPILEPSY; GERMANY; HUMANS; MIDDLE AGED; PIRACETAM; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; TRIAZINES; VALPROIC ACID; YOUNG ADULT;

EID: 84868206213     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6509-3     Document Type: Article

References (42)

1. Alacqua M, Trifiro G, Spina E, Moretti S, Tari DU, Bramanti P, Caputi AP, Arcoraci V (2009) Newer and older antiepileptic drug use in southern Italy: a population-based study during the years 2003-2005. Epilepsy Res 85:107-113
2. Andermann F, Duh MS, Gosselin A, Paradis PE (2007) Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia 48:464-469 (Pubitemid 46365174)
3. Banerjee PN, Filippi D, Allen HW (2009) The descriptive epidemiology of epilepsy - a review. Epilepsy Res 85:31-45
4. Banfi R, Borselli G, Marinai C, Borgheresi A, Cavalieri A (1995) Epidemiological study of epilepsy by monitoring prescriptions of antiepileptic drugs. Pharm World Sci 17:138-140
5. Becher H, Kostev K, Schroder-Bernhardi D (2009) Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617-626
6. Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F (2004) Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia 45:171-178 (Pubitemid 38174124)
7. Beghi M, Savica R, Beghi E, Nobili A, Garattini L (2009) Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue. Drugs Aging 26:157-168
8. Bielen I, Sruk A, Planjar-Prvan M, Cvitanovic-Sojat L, Kosicek M, Bergman-Markovic B, Baraba R, Butkovic-Soldo S (2009) Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey. Coll Antropol 33:659-663
9. Duh MS, Paradis PE, Latremouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J (2009) The risks and costs of multiple-generic substitution of topiramate. Neurology 72:2122-2129
10. Ekman M, Forsgren L (2004) Economic evidence in epilepsy: a review. Eur J Health Econ 5(Suppl 1):S36-S42 (Pubitemid 39440396)
11. Faught E, Richman J, Martin R, Funkhouser E, Foushee R, Kratt P, Kim Y, Clements K, Cohen N, Adoboe D, Knowlton R, Pisu M (2012) Incidence and prevalence of epilepsy among older US Medicare beneficiaries. Neurology 78:448-453
12. Forsgren I, Beghi E, Ekman M (2005) Cost of epilepsy in Europe. Eur J Neurol 12(Suppl 1):54-58 (Pubitemid 40755605)
13. Forsgren L, Beghi E, Oun A, Sillanpaa M (2005) The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 12:245-253 (Pubitemid 40477131)
14. Gissler M, Jarvelin MR, Louhiala P, Hemminki E (1999) Boys have more health problems in childhood than girls: follow-up of the 1987 Finnish birth cohort. Acta Paediatr 88:310-314 (Pubitemid 29144139)
15. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jonsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, den Bergh PV, van OJ, Vos P, Xu W, Wittchen HU, Jonsson B, Olesen J (2011) Cost of disorders of the brain in Europe 2010. Eur Neu-ropsychopharmacol 21:718-779
16. Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R (2006) Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Epilepsia 47:2165-2172 (Pubitemid 44952272)
17. Heaney DC, Sander JW (2007) Antiepileptic drugs: generic versus branded treatments. Lancet Neurol 6:465-468 (Pubitemid 46551869)
18. Helmers SL, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latremouille-Viau D, Lefebvre P, Labiner DM (2010) Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy Behav 18:437-444
19. Holden EW, Grossman E, Nguyen HT, Gunter MJ, Grebosky B, Von WA, Nelson L, Robinson S, Thurman DJ (2005) Developing a computer algorithm to identify epilepsy cases in managed care organizations. Dis Manag 8:1-14 (Pubitemid 40316209)
20. Hollingworth SA, Eadie MJ (2010) Antiepileptic drugs in Australia: 2002-2007. Pharmacoepidemiol Drug Saf 19:82-89
21. Hsieh LP, Huang CY (2009) Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database. Epilepsy Res 84:21-27
22. Johannessen LC, Larsson PG, Rytter E, Johannessen SI (2009) Antiepileptic drugs in epilepsy and other disorders - a population-based study of prescriptions. Epilepsy Res 87:31-39
23. Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH (2010) Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs 70:605-621
24. Kramer G, Biraben A, Carreno M, Guekht A, de Haan GJ, Jedrzejczak J, Josephs D, RK van, Zaccara G (2007) Current approaches to the use of generic antiepileptic drugs. Epilepsy Behav 11:46-52 (Pubitemid 47087191)
25. Labiner DM, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latremouille-Viau D, Lefebvre P, Helmers SL (2010) Generic antiepileptic drugs and associated medical resource utilization in the United States. Neurology 74:1566-1574
26. Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, BA de (2001) Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 54:1181-1186 (Pubitemid 33033249)
27. Marson AG, Al Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:1000-1015 (Pubitemid 46436124)
28. Marson AG, Al Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:1016-1026 (Pubitemid 46436125)
29. Oles KS, Gal P, Penry JK, Tapscott WK (1987) Use of antiepi-leptic drugs in the elderly population. Public Health Rep 102:335-337 (Pubitemid 17088526)
30. Oun A, Haldre S, Magi M (2006) Use of antiepileptic drugs in Estonia: an epidemiologic study of adult epilepsy. Eur J Neurol 13:465-470 (Pubitemid 43823360)
31. Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P (2007) Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 48:2224-2233 (Pubitemid 350243405)
32. Roberts SJ, Feely M, Bateman DN (1998) Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992-1995. Seizure 7:127-132 (Pubitemid 28226937)
33. Rochat P, Hallas J, Gaist D, Friis ML (2001) Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand 104:6-11 (Pubitemid 32588393)
34. Sancho J, Pena P, Rufo M, Palacios G, Masramon X, Rejas J (2008) Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study). Epilepsy Res 81:176-187
35. Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, Caputi AP, Musolino R, Spina E, Trifiro G (2007) Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. Eur J Neurol 14:1317-1321 (Pubitemid 350135294)
36. Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Mendelson MA, Lawhorne L (1998) An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc 46:1137-1141 (Pubitemid 28415605)
37. Shackleton DP, Westendorp RG, Kasteleijn-Nolst Trenite DG, de BA, Herings RM (1997) Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J Clin Epidemiol 50:1061-1068 (Pubitemid 27450367)
38. Strzelczyk A, Reese JP, Dodel R, Hamer HM (2008) Cost of epilepsy: a systematic review. Pharmacoeconomics 26:463-476 (Pubitemid 351704857)
39. Tetto A, Manzoni P, Millul A, Beghi E, Garattini L, Tartara A, Avanzini G (2002) The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy Res 48:207-216 (Pubitemid 34252905)
40. Tsiropoulos I, Gichangi A, Andersen M, Bjerrum L, Gaist D, Hallas J (2006) Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand 113:405-411 (Pubitemid 44046326)
41. van de Vrie-Hoekstra NW, de Vries TW, van den Berg PB, Brouwer OF, de Jong-van den Berg LT (2008) Antiepileptic drug utilization in children from 1997 to 2005 - a study from the Netherlands. Eur J Clin Pharmacol 64:1013-1020
42. Waaler PE, Blom BH, Skeidsvoll H, Mykletun A (2000) Prevalence, classification, and severity of epilepsy in children in western Norway. Epilepsia 41:802-810 (Pubitemid 30439570)